Literature DB >> 8567876

Simultaneous amplification of the two most frequent mutations of infantile Tay-Sachs disease in single blastomeres.

K Sermon1, W Lissens, Z P Nagy, A Van Steirteghem, I Liebaers.   

Abstract

Tay-Sachs disease is a lysosomal storage disease, which in its most severe form leads inexorably to death during infancy. We have developed a method for preimplantation diagnosis, using polymerase chain reaction (PCR) technology, by which the two most frequent mutations occurring in this disease can be amplified simultaneously. We have tested this method on single blastomeres and have compared four lysis methods: (i) boiling in water at 94 degrees C for 15 or (ii) 30 min, and (iii) incubation in an alkaline lysis buffer for 30 min at 94 degrees C or (iv) at 65 degrees C for 10 min. The amplification percentages were 21, 67, 71 and 91% respectively.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8567876     DOI: 10.1093/oxfordjournals.humrep.a136270

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  4 in total

Review 1.  Molecular diagnostics in preimplantation genetic diagnosis.

Authors:  Alan R Thornhill; Karen Snow
Journal:  J Mol Diagn       Date:  2002-02       Impact factor: 5.568

2.  Polymerase chain reaction amplification specificity: incidence of allele dropout using different DNA preparation methods for heterozygous single cells.

Authors:  S A Gitlin; S E Lanzendorf; W E Gibbons
Journal:  J Assist Reprod Genet       Date:  1996-02       Impact factor: 3.412

3.  Primer system for single cell detection of double mutation for Tay-Sachs disease.

Authors:  M C Liu; K C Drury; S Kipersztok; W Zheng; R S Williams
Journal:  J Assist Reprod Genet       Date:  2000-02       Impact factor: 3.412

4.  The single cell as a tool for genetic testing: credibility, precision, implication.

Authors:  Keren Dotan; Baruch Feldman; Boleslaw Goldman; Yehuda Peri; Leah Peleg
Journal:  J Assist Reprod Genet       Date:  2010-03-03       Impact factor: 3.412

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.